PL1652843T3 - Pochodne amidu - Google Patents

Pochodne amidu

Info

Publication number
PL1652843T3
PL1652843T3 PL04748296T PL04748296T PL1652843T3 PL 1652843 T3 PL1652843 T3 PL 1652843T3 PL 04748296 T PL04748296 T PL 04748296T PL 04748296 T PL04748296 T PL 04748296T PL 1652843 T3 PL1652843 T3 PL 1652843T3
Authority
PL
Poland
Prior art keywords
amide derivatives
amide
derivatives
Prior art date
Application number
PL04748296T
Other languages
English (en)
Inventor
Toru Kontani
Junji Miyata
Wataru Hamaguchi
Tomoaki Kawano
Akio Kamikawa
Hiroshi Suzuki
Kenji Sudo
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of PL1652843T3 publication Critical patent/PL1652843T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
PL04748296T 2003-08-08 2004-08-05 Pochodne amidu PL1652843T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003290850 2003-08-08
EP04748296.3A EP1652843B1 (en) 2003-08-08 2004-08-05 Amide derivatives
PCT/JP2004/011573 WO2005014559A1 (ja) 2003-08-08 2004-08-05 アミド誘導体

Publications (1)

Publication Number Publication Date
PL1652843T3 true PL1652843T3 (pl) 2014-09-30

Family

ID=34114142

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04748296T PL1652843T3 (pl) 2003-08-08 2004-08-05 Pochodne amidu

Country Status (19)

Country Link
US (2) US7465748B2 (pl)
EP (1) EP1652843B1 (pl)
JP (1) JP4549974B2 (pl)
KR (1) KR101157074B1 (pl)
CN (1) CN100445271C (pl)
AU (1) AU2004263448B2 (pl)
BR (1) BRPI0413430B8 (pl)
CA (1) CA2535199C (pl)
CY (1) CY1115461T1 (pl)
DK (1) DK1652843T3 (pl)
ES (1) ES2462292T3 (pl)
MX (1) MXPA06001526A (pl)
NO (1) NO335467B1 (pl)
PL (1) PL1652843T3 (pl)
PT (1) PT1652843E (pl)
RU (1) RU2336273C2 (pl)
SI (1) SI1652843T1 (pl)
TW (1) TW200505894A (pl)
WO (1) WO2005014559A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003055482A1 (en) * 2001-12-21 2003-07-10 Novo Nordisk A/S Amide derivatives as gk activators
AU2003243921B2 (en) * 2002-06-27 2009-05-07 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative
PT1723128E (pt) * 2004-01-06 2013-02-27 Novo Nordisk As Heteroaril-ureias e o seu uso como activadores da glicoquinase
CA2596851A1 (en) * 2005-02-02 2006-08-10 Astellas Pharma Inc. Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus
EP1844775B1 (en) * 2005-02-02 2010-08-11 Astellas Pharma Inc. Therapeutic agent for the treatment of herpes progenitalis after development of lesions
CN101111247A (zh) * 2005-02-02 2008-01-23 安斯泰来制药有限公司 疱疹病毒相关疾病的预防或治疗剂
JP5011739B2 (ja) * 2005-02-03 2012-08-29 アステラス製薬株式会社 テトラヒドロ−２ｈ−チオピラン−４−カルボキサミド誘導体を含有する医薬組成物
KR20080024211A (ko) * 2005-07-08 2008-03-17 노보 노르디스크 에이/에스 디시클로알킬 우레아 글루코키나제 활성제
JP2009500378A (ja) * 2005-07-08 2009-01-08 ノボ・ノルデイスク・エー／エス グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
BRPI0612996A2 (pt) * 2005-07-14 2010-12-14 Novo Nordisk As ativadores de urÉia glucocinase
US8138185B2 (en) * 2007-01-09 2012-03-20 Novo Nordisk A/S Urea glucokinase activators
AU2008204530B2 (en) * 2007-01-11 2013-08-01 Vtv Therapeutics Llc Urea glucokinase activators
DE102008014523A1 (de) * 2008-03-15 2009-09-17 Robert Bosch Gmbh Heizgerät
CA2728890C (en) * 2008-04-02 2016-05-03 Astellas Pharma Inc. Amide derivative-containing pharmaceutical composition
US8598355B2 (en) * 2008-05-14 2013-12-03 Astellas Pharma Inc. Amide compound
JPWO2010047295A1 (ja) * 2008-10-20 2012-03-22 アステラス製薬株式会社 帯状疱疹関連痛の予防又は治療薬
CN108623577B (zh) * 2018-05-08 2020-09-25 山东百诺医药股份有限公司 阿莫奈韦及其中间体的制备方法
AU2019287437A1 (en) 2018-06-12 2020-09-10 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
WO2020038812A1 (en) * 2018-08-20 2020-02-27 Rijksuniversiteit Groningen New process for the preparation of amenamevir
TW202038947A (zh) 2018-11-28 2020-11-01 德商創新分子有限責任公司 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑
WO2021167840A1 (en) 2020-02-18 2021-08-26 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288091B1 (en) * 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
WO1997024343A1 (en) 1995-12-29 1997-07-10 Boehringer Ingelheim Pharmaceuticals, Inc. Phenyl thiazole derivatives with anti herpes virus properties
AU3289299A (en) * 1998-02-19 1999-09-06 Tularik Inc. Antiviral agents
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
JP2002539119A (ja) * 1999-03-08 2002-11-19 バイエル アクチェンゲゼルシャフト チアゾリルウレア誘導体および抗ウイルス剤としてのそれらの使用
JP2003500382A (ja) 1999-05-24 2003-01-07 シーオーアール セラピューティクス インコーポレイテッド Ｘａ因子の阻害剤
AU5283800A (en) 1999-05-24 2000-12-12 Cor Therapeutics, Inc. Inhibitors of factor xa
CN1473157A (zh) 2000-11-10 2004-02-04 ֮����ҩ��ʽ���� 酰胺衍生物
DE10139060A1 (de) 2001-08-08 2003-02-20 Merck Patent Gmbh Phenylderivate
WO2003095435A1 (en) 2002-05-09 2003-11-20 Yamanouchi Pharmaceutical Co., Ltd. Amide derivatives
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative

Also Published As

Publication number Publication date
KR101157074B1 (ko) 2012-06-22
CY1115461T1 (el) 2017-01-04
CA2535199A1 (en) 2005-02-17
US6903125B2 (en) 2005-06-07
RU2336273C2 (ru) 2008-10-20
US7465748B2 (en) 2008-12-16
TW200505894A (en) 2005-02-16
BRPI0413430A (pt) 2006-10-17
TWI341311B (pl) 2011-05-01
WO2005014559A1 (ja) 2005-02-17
BRPI0413430B8 (pt) 2021-05-25
CN1832930A (zh) 2006-09-13
US20060229295A1 (en) 2006-10-12
CA2535199C (en) 2010-12-14
NO335467B1 (no) 2014-12-15
AU2004263448A1 (en) 2005-02-17
ES2462292T3 (es) 2014-05-22
KR20060073928A (ko) 2006-06-29
AU2004263448B2 (en) 2009-02-05
JP4549974B2 (ja) 2010-09-22
PT1652843E (pt) 2014-06-02
EP1652843A4 (en) 2010-07-28
JPWO2005014559A1 (ja) 2006-10-05
NO20061100L (no) 2006-03-07
US20050032855A1 (en) 2005-02-10
RU2006106922A (ru) 2006-08-27
BRPI0413430B1 (pt) 2019-04-30
MXPA06001526A (es) 2006-05-25
EP1652843B1 (en) 2014-04-02
DK1652843T3 (da) 2014-05-05
SI1652843T1 (sl) 2014-06-30
EP1652843A1 (en) 2006-05-03
CN100445271C (zh) 2008-12-24

Similar Documents

Publication Publication Date Title
IL175065A0 (en) Amide derivatives
IL211894A0 (en) Amide derivatives
PL378559A1 (pl) Pochodne piperydynobenzenosulfonoamidu
IL169905A0 (en) Novel 2-pyridinecarboxamide derivatives
GB0317665D0 (en) Qinazoline derivatives
IL183657A0 (en) Amide derivatives
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
PT1682493E (pt) Derivados de aminoacetonitrilo
IL204829A0 (en) Aniline derivatives
SI1606277T1 (sl) Derivati imidazol-4-il-etinil-piridina
TWI368482B (en) New 2-pyridinylethylbenzamide derivatives
EP1652843A4 (en) AMIDE DERIVATIVES
IL176562A0 (en) Amidopyrazole derivative
IL175189A0 (en) N-thiazol-2-yl-benzamide derivatives
GB0329572D0 (en) Amide derivatives
PT1706373E (pt) Derivados de amidoacetonitrilo
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
ZA200602131B (en) Amide type carboxamide derivatives
GB2403474B (en) Amide derivatives
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
AU2003235889A8 (en) Amide derivatives
GB0319793D0 (en) Pyridinylmorpholine derivatives
AU2003243397A8 (en) Homo-camptothecin derivatives
ZA200705150B (en) Amide derivatives